PE20070157A1 - Composicion farmaceutica oftalmica que comprende azitromicina - Google Patents

Composicion farmaceutica oftalmica que comprende azitromicina

Info

Publication number
PE20070157A1
PE20070157A1 PE2006000412A PE2006000412A PE20070157A1 PE 20070157 A1 PE20070157 A1 PE 20070157A1 PE 2006000412 A PE2006000412 A PE 2006000412A PE 2006000412 A PE2006000412 A PE 2006000412A PE 20070157 A1 PE20070157 A1 PE 20070157A1
Authority
PE
Peru
Prior art keywords
pharmaceutical composition
azitromycin
composition including
ophthalmic pharmaceutical
eye
Prior art date
Application number
PE2006000412A
Other languages
English (en)
Inventor
Jacques Luyckx
Frederic Pilotaz
Pablo Goldschmidt
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35445697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070157(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thea Lab filed Critical Thea Lab
Publication of PE20070157A1 publication Critical patent/PE20070157A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE AZITROMICINA O N-METIL-11-AZA-10-DESOXO-10-DIHIDRO-ERITROMICINA, EN UNA CONCENTRACION DE 1 AL 2% EN PESO DE DIHIDRATO DE AZITROMICINA; EN SOLUCION EN UN VEHICULO OLEOSO CONSTITUIDO POR TRIGLICERIDOS DE ACIDOS GRASOS DE CADENA DE LONGITUD MEDIA (TCM) TAL COMO ACDIO CAPRICO Y ACIDO CAPRILICO. ESTA COMPOSICION ES DE ADMINISTRACION TOPICA PARA LA APLICACION DE DOS VECES AL DIA EN CADA OJO DURANTE AL MENOS CUATRO DIAS, SIENDO UTIL EN EL TRATAMIENTO Y PREVENCION DE INFECCIONES OCULARES
PE2006000412A 2005-04-22 2006-04-20 Composicion farmaceutica oftalmica que comprende azitromicina PE20070157A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504069A FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires

Publications (1)

Publication Number Publication Date
PE20070157A1 true PE20070157A1 (es) 2007-03-09

Family

ID=35445697

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000412A PE20070157A1 (es) 2005-04-22 2006-04-20 Composicion farmaceutica oftalmica que comprende azitromicina

Country Status (25)

Country Link
US (2) US20060252711A1 (es)
EP (1) EP1877066A1 (es)
JP (1) JP2008536908A (es)
KR (1) KR20080008377A (es)
CN (1) CN101163486B (es)
AR (1) AR053591A1 (es)
AU (1) AU2006238595A1 (es)
BR (1) BRPI0608375A2 (es)
CA (1) CA2603833A1 (es)
EA (1) EA200702295A1 (es)
FR (1) FR2884716B1 (es)
HK (1) HK1119064A1 (es)
IL (1) IL186092A (es)
JO (1) JO3448B1 (es)
MA (1) MA29467B1 (es)
MX (1) MX2007013054A (es)
MY (1) MY169533A (es)
NO (1) NO20075943L (es)
PE (1) PE20070157A1 (es)
SG (1) SG164382A1 (es)
TN (1) TNSN07370A1 (es)
TW (1) TWI430799B (es)
UA (1) UA94708C2 (es)
WO (1) WO2006111844A1 (es)
ZA (1) ZA200709872B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098219A1 (en) 2008-03-05 2009-09-09 PARI Pharma GmbH Macrolide compositions having improved taste and stability
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001505855A (ja) * 1996-12-09 2001-05-08 ボシュ アンド ロム インコーポレイテッド 使い捨て可撓容器
DE69825128T3 (de) * 1997-12-02 2010-05-06 Pfizer Products Inc., Groton Verwendung von azithromycin zur topischen behandlung von augeninfektionen
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Also Published As

Publication number Publication date
MY169533A (en) 2019-04-22
WO2006111844A1 (fr) 2006-10-26
CN101163486B (zh) 2011-11-30
AU2006238595A1 (en) 2006-10-26
NO20075943L (no) 2008-01-15
BRPI0608375A2 (pt) 2010-08-31
CA2603833A1 (fr) 2006-10-26
ZA200709872B (en) 2008-09-25
TNSN07370A1 (fr) 2009-03-17
FR2884716B1 (fr) 2009-08-21
JO3448B1 (ar) 2020-07-05
IL186092A0 (en) 2008-01-20
US20060252711A1 (en) 2006-11-09
TW200716142A (en) 2007-05-01
AR053591A1 (es) 2007-05-09
EP1877066A1 (fr) 2008-01-16
US20100069315A1 (en) 2010-03-18
UA94708C2 (ru) 2011-06-10
IL186092A (en) 2016-05-31
MA29467B1 (fr) 2008-05-02
HK1119064A1 (en) 2009-02-27
CN101163486A (zh) 2008-04-16
EA200702295A1 (ru) 2008-04-28
FR2884716A1 (fr) 2006-10-27
MX2007013054A (es) 2008-01-14
TWI430799B (zh) 2014-03-21
KR20080008377A (ko) 2008-01-23
SG164382A1 (en) 2010-09-29
JP2008536908A (ja) 2008-09-11

Similar Documents

Publication Publication Date Title
CY1120888T1 (el) Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
AR073123A1 (es) Composicion farmaceutica que comprende un taxano sustancialmente amorfo para utilizarse en el tratamiento de la enfermedad neoplasica
EA201490489A1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
PE20120777A1 (es) Combinacion de un inhibidor de nucleosido polimerasa con un inhibidor de proteasa macrociclica y su uso en el tratamiento de hepatitis c, fibrosis hepatica y funcion hepatica alterada
CL2008000593A1 (es) Uso de compuestos derivados de heterociclos sustituidos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad aterosclerotica de las arterias entre otras enfermedades.
EA201000897A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
PE20121524A1 (es) Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos
RS52913B (en) SUBcutaneous FORMULATION OF ANTI-HER2 ANTIBODIES
UA108641C2 (uk) Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
GT201200126A (es) Derivados de la cromenona con actividad anti-tumoral
GT200900175A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
CL2008000594A1 (es) Uso de compuestos derivados de heterociclos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad arterial coronaria entre otras enfermedades.
BR112014018421A8 (pt) Composições antimicrobianas compreendendo dgla, 15-ohepa e/ou 15-hetre e métodos de uso das mesmas
CR10166A (es) Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania
GT200600463A (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
BRPI0506493A (pt) combinações terapêuticas
AR080368A1 (es) Disoluciones acuosas transparentes de acetonido de fluocinolona para el tratamiento de la inflamacion de oido
FR2930732B1 (fr) Composition et procede pour la destruction de polluants organophosphores et/ou organosoufres
CA2692191C (en) Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases
PE20070157A1 (es) Composicion farmaceutica oftalmica que comprende azitromicina
AR055939A1 (es) Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso
CR9991A (es) Nuevo derivado de pleuromutilina y su uso
AR090244A1 (es) Formulacion de anticuerpo anti-selectina p

Legal Events

Date Code Title Description
FC Refusal
AE Restoration of lapsed or forfeited application
FC Refusal